Key result
PCI shows no difference in 10-year all-cause mortality compared to CABG.
Why the study?
Does PCI compared to CABG improve long-term survival in patients with complex coronary artery disease?
Does PCI compared to CABG improve long-term survival in patients with complex coronary artery disease?
Ten-year follow-up of the SYNTAX trial demonstrated comparable all-cause mortality between PCI with first-generation DES and CABG overall, though CABG showed a survival benefit in the 3-vessel disease subgroup.
Answers are grounded in this paper and cite their sources.
Supports equipoise for PCI or CABG in complex CAD; leaves open need for contemporary stent trials.
The SYNTAX trial randomized patients equally eligible for coronary artery bypass grafting or percutaneous coronary intervention using the Heart Team approach. The SYNTAXES study achieved a follow-up rate of 93.8% and reported the 10-year vital status. Factors associated with increased mortality at 10 years were pharmacologically treated diabetes mellitus, increased waist circumference, reduced left ventricular function, prior cerebrovascular and peripheral vascular disease, western Europe and North American descent, current smoking, chronic obstructive pulmonary disease, elevated C-reactive protein, anemia, and an increase in HbA1c. Procedural factors associated with higher 10 years mortality include periprocedural myocardial infarction, extensive stenting, small stents, ≥1 heavily calcified lesion, ≥1 bifurcation lesion, residual SYNTAX score >8, and staged percutaneous coronary intervention. Optimal medical therapy at 5 years, use of statins, on-pump coronary artery bypass grafting, multiple arterial grafts, and higher physical component score and mental component score were associated with lower mortality at 10 years. Numerous scores and prediction models were developed to help individualize risk assessment. Machine learning has emerged as a novel approach for developing risk models.
No takes yet. Share an insight, caveat, or question.
Serruys et al. (2023) conducted a review in De novo 3-vessel disease or left main coronary artery disease (n=1,800). Percutaneous coronary intervention (PCI) vs. Coronary artery bypass grafting (CABG) was evaluated on All-cause mortality at 10 years (HR 1.19, 95% CI 0.99-1.43, p=0.066). At 10 years, all-cause mortality was 27.46% with PCI using first-generation drug-eluting stents compared to 23.63% with CABG, showing no significant difference.
Synapse has enriched 10 related papers. Consider them for comparative context: